Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J, Suchy-Dicey A, Yoshimoto M, Lensch MW, Yoder MC, Garcia-Cardena G, Daley GQ. 2009. Biomechanical forces promote embryonic haematopoiesis. Nature 459:1131–1135.
Altafaj X, Dierssen M, Baamonde C, Marti E, Visa J, Guimera J, Oset M, Gonzalez JR, Florez J, Fillat C, Estivill X. 2001. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing
Dyrk1A (
minibrain), a murine model of Down’s syndrome. Hum Mol Genet 10:1915–1923.
Asou N. 2003. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Crit Rev Oncol Hematol 45:129–150.
Bain BJ. 1995. Blood Cells: A Practical Guide. 2th ednWiley Blackwell; Chicester, West Sussex, UK:
Cho IC, Park HB, Yoo CK, Lee GJ, Lim HT, Lee JB, Jung EJ, Ko MS, Lee JH, Jeon JT. 2011. QTL analysis of white blood cell, platelet and red blood cell-related traits in an F2 intercross between Landrace and Korean native pigs. Anim Genet 42:621–626.
David O, Fiorucci GC, Tosi MT, Altare F, Valori A, Saracco P, Asinardi P, Ramenghi U, Gabutti V. 1996. Hematological studies in children with Down syndrome. Pediatr Hematol Oncol 13:271–275.
de Alarcon PA, Miceli LA, Mazur EM, Smith K. 1984. Down’s syndrome and increased mean corpuscular volume (MCV), mean platelet volume (MPV) and neutrophil alkaline phosphatase (NAP). Environ Sci Technol Pediatr Res 18:235A.
Freiberg AS. 2012. A case based approach to severe microcytic anemia in children. New Advances in the Basic and Clinical Gastroenterology. Brzozowski T, editorINTECH Open Access Publisher; Rijeka, Croatia: p. 243–266.
Gosset P, Ghezala GA, Korn B, Yaspo ML, Poutska A, Lehrach H, Sinet PM, Creau N. 1997. A new inward rectifier potassium channel gene (KCNJ15) localized on chromosome 21 in the Down syndrome chromosome region 1 (DCR1). Genomics 44:237–241.
Kivivuori SM, Rajantie J, Siimes MA. 1996. Peripheral blood cell counts in infants with Down’s syndrome. Clin Genet 49:15–19.
Okamoto K, Iwasaki N, Nishimura C, Doi K, Noiri E, Nakamura S, Takizawa M, Ogata M, Fujimaki R, Grarup N, et al. 2010. Identification of
KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. Am J Hum Genet 86:54–64.
Okuda T, Nishimura M, Nakao M, Fujita Y. 2001. RUNX1/AML1: a central player in hematopoiesis. Int J Hematol 74:252–257.
Ron M, Weller JI. 2007. From QTL to QTN identification in livestock--winning by points rather than knock-out: A review. Anim Genet 38:429–439.
Shindoh N, Kudoh J, Maeda H, Yamaki A, Minoshima S, Shimizu Y, Shimizu N. 1996. Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from “the Down syndrome critical region” of chromosome 21. Biochem Biophys Res Commun 225:92–99.
Speck NA, Gilliland DG. 2002. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2:502–513.
van Bon BW, Hoischen A, Hehir-Kwa J, de Brouwer AP, Ruivenkamp C, Gijsbers AC, Marcelis CL, de Leeuw N, Veltman JA, Brunner HG, de Vries BB. 2011. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin Genet 79:296–299.
Wachtel TJ, Pueschel SM. 1991. Macrocytosis in Down syndrome. Am J Ment Retard 95:417–420.
Yoshikawa M, Senzaki K, Yokomizo T, Takahashi S, Ozaki S, Shiga T. 2007. Runx1 selectively regulates cell fate specification and axonal projections of dorsal root ganglion neurons. Dev Biol 303:663–674.